Matinas biopharma to webcast conference call to discuss second quarter 2024 financial results and provide a business update on august 14, 2024

Bedminster, n.j., aug. 07, 2024 (globe newswire) -- matinas biopharma holdings, inc. (nyse american: mtnb), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (lnc) platform delivery technology, announces that it will report second quarter 2024 financial results after market close on wednesday, august 14, 2024. matinas management will host an investment community conference call and webcast to discuss financial results and provide a business update that day at 4:30 p.m. eastern time (1:30 p.m. pacific time).
MTNB Ratings Summary
MTNB Quant Ranking